SP110 and bacterial infectious disease: To determine whether loss of Sp110 confers susceptibility to bacterial infections, we used CRISPR/Cas9 to target exon 3 of Sp110 to generate Sp110–/– mice on the C57BL/6 (B6) background (Figure 1—figure supplement 1).